Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score–matched study

Alex Bataller, Koji Sasaki, Samuel Urrutia, Guillermo Montalban-Bravo, Alexandre Bazinet, Kelly Chien, Danielle Hammond, Ian M. Bouligny, Mahesh Swaminathan, Ghayas Issa, Nicholas Short, Naval Daver, Courtney D. DiNardo, Tapan Kadia, Elias Jabbour, Farhad Ravandi, Gail J. Roboz, Michael Savona, Elizabeth A. Griffiths, James McCloskey, Olatoyosi Odenike, Aram Oganesian, Harold N. Keer, Mohammad Azab, Hagop Kantarjian, Guillermo Garcia-Manero

Open source

DOI: 10.1038/s41408-025-01245-5
Published: 2025-03-31
Container: Blood Cancer Journal
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41408-025-01245-5,
  title = {Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score–matched study},
  author = {Alex Bataller and Koji Sasaki and Samuel Urrutia and Guillermo Montalban-Bravo and Alexandre Bazinet and Kelly Chien and Danielle Hammond and Ian M. Bouligny and Mahesh Swaminathan and Ghayas Issa and Nicholas Short and Naval Daver and Courtney D. DiNardo and Tapan Kadia and Elias Jabbour and Farhad Ravandi and Gail J. Roboz and Michael Savona and Elizabeth A. Griffiths and James McCloskey and Olatoyosi Odenike and Aram Oganesian and Harold N. Keer and Mohammad Azab and Hagop Kantarjian and Guillermo Garcia-Manero},
  year = {2025},
  journal = {Blood Cancer Journal},
  doi = {10.1038/s41408-025-01245-5},
  url = {https://doi.org/10.1038/s41408-025-01245-5}
}

RIS

TY  - JOUR
TI  - Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score–matched study
AU  - Alex Bataller
AU  - Koji Sasaki
AU  - Samuel Urrutia
AU  - Guillermo Montalban-Bravo
AU  - Alexandre Bazinet
AU  - Kelly Chien
AU  - Danielle Hammond
AU  - Ian M. Bouligny
AU  - Mahesh Swaminathan
AU  - Ghayas Issa
AU  - Nicholas Short
AU  - Naval Daver
AU  - Courtney D. DiNardo
AU  - Tapan Kadia
AU  - Elias Jabbour
AU  - Farhad Ravandi
AU  - Gail J. Roboz
AU  - Michael Savona
AU  - Elizabeth A. Griffiths
AU  - James McCloskey
AU  - Olatoyosi Odenike
AU  - Aram Oganesian
AU  - Harold N. Keer
AU  - Mohammad Azab
AU  - Hagop Kantarjian
AU  - Guillermo Garcia-Manero
PY  - 2025
JO  - Blood Cancer Journal
DO  - 10.1038/s41408-025-01245-5
UR  - https://doi.org/10.1038/s41408-025-01245-5
ER  -

APA

Bataller, A., Sasaki, K., Urrutia, S., Montalban-Bravo, G., Bazinet, A., Chien, K., Hammond, D., Bouligny, I. M., Swaminathan, M., Issa, G., Short, N., Daver, N., DiNardo, C. D., Kadia, T., Jabbour, E., Ravandi, F., Roboz, G. J., Savona, M., Griffiths, E. A., McCloskey, J., Odenike, O., Oganesian, A., Keer, H. N., Azab, M., Kantarjian, H., & Garcia-Manero, G. (2025). Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score–matched study. Blood Cancer Journal. https://doi.org/10.1038/s41408-025-01245-5

Source records

crossref · retrieved 2026-09-25T20:10:53.932Z